Celgene secured the money two months after raising $100m from the Kuwait Investment Authority and additional funding from Blackberry.
Pharmaceutical company Celgene agreed yesterday to invest $25m in NantHealth, a US-based developer of a cloud computing platform for healthcare.
Celgene previously invested $75m in NantHealth’s sister company, NantBioScience, earlier this year, and its commitment to NantHealth is part of a collaboration that will involve Celgene accessing NantHealth’s knowledge base and clinical operating system to aid clinicians and medical researchers in developing cancer drugs.
NantHealth, part of the NantWorks group of companies, secured $100m in funding from sovereign wealth fund…
